Public company · Biotech
Intellia therapeutics IPO
Intellia therapeutics is a biotech company that went public in 2016.
Listed NTLA HQ US Venture-backed
- Status
- listed
- Exchange
- —
- Ticker
- NTLA
- Listed
- May 6, 2016
- Price range
- —
- Offer price
- $18.00
- Proceeds
- —
- Mkt cap at IPO
- 800.0M
Advisors and underwriters
| Firm | Role | Type |
|---|---|---|
| Credit Suisse | Lead-left bookrunner | investment bank |
| Jefferies | Lead bookrunner | investment bank |
Timeline
-
Priced IPO
May 5, 2016
-
Listed on exchange
May 6, 2016
Frequently asked questions
When is Intellia therapeutics expected to IPO?
Intellia therapeutics listed on May 6, 2016 on the undefined under the ticker NTLA.
Who is leading the Intellia therapeutics IPO?
The lead bookrunner is credit suisse. See the full advisor table on this page.